Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,043 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The perioperative administration of dexamethasone and infection (PADDI) trial protocol: rationale and design of a pragmatic multicentre non-inferiority study.
Corcoran TB, Myles PS, Forbes AB, O'Loughlin E, Leslie K, Story D, Short TG, Chan MT, Coutts P, Sidhu J, Cheng AC, Bach LA, Ho KM; Australian and New Zealand College of Anaesthetists Clinical Trials Network (ANZCA), and the Australian Society for Infectious Diseases (ASID) Clinical Research Network. Corcoran TB, et al. BMJ Open. 2019 Sep 6;9(9):e030402. doi: 10.1136/bmjopen-2019-030402. BMJ Open. 2019. PMID: 31494615 Free PMC article.
Development of a Core Outcome Set for Studies Assessing Interventions for Diabetes-Related Foot Ulceration.
Staniszewska A, Game F, Nixon J, Russell D, Armstrong DG, Ashmore C, Bus SA, Chung J, Chuter V, Dhatariya K, Dovell G, Edmonds M, Fitridge R, Gooday C, Hamilton EJ, Jones A, Kavarthapu V, Lavery LA, Mills JL, Monteiro-Soares M, Osborne-Grinter M, Peters EJG, Shalhoub J, van Netten J, Wukich DK, Hinchliffe RJ. Staniszewska A, et al. Diabetes Care. 2024 Nov 1;47(11):1958-1968. doi: 10.2337/dc24-1112. Diabetes Care. 2024. PMID: 39240785 Free PMC article.
First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer.
Lakhani NJ, Stewart D, Richardson DL, Dockery LE, Van Le L, Call J, Rangwala F, Wang G, Ma B, Metenou S, Huguet J, Offman E, Pandite L, Hamilton E. Lakhani NJ, et al. Among authors: hamilton e. J Immunother Cancer. 2025 Jan 11;13(1):e010565. doi: 10.1136/jitc-2024-010565. J Immunother Cancer. 2025. PMID: 39800375 Free article. Clinical Trial.
Quality-adjusted time without symptoms or toxicity analysis of trastuzumab deruxtecan versus trastuzumab emtansine in HER2- positive metastatic breast cancer patients based on secondary use of the DESTINY-Breast03 trial.
Dennis N, Dunton K, Livings C, Bogoeva N, Bourke S, Oluboyede Y, Hamilton E, Iwata H, Cortés J. Dennis N, et al. Among authors: hamilton e. Eur J Cancer. 2024 Dec 26;217:115192. doi: 10.1016/j.ejca.2024.115192. Online ahead of print. Eur J Cancer. 2024. PMID: 39798264 Free article.
Phase 2 Open-Label Study of Sacituzumab Govitecan as Second-Line Therapy in Patients With Extensive-Stage Small Cell Lung Cancer: Results From TROPiCS-03.
Dowlati A, Chiang AC, Cervantes A, Babu S, Hamilton E, Wong SF, Tazbirkova A, Sullivan IG, van Marcke C, Italiano A, Patel J, Mekan S, Wu T, Waqar SN. Dowlati A, et al. Among authors: hamilton e. J Thorac Oncol. 2025 Jan 2:S1556-0864(24)02549-8. doi: 10.1016/j.jtho.2024.12.028. Online ahead of print. J Thorac Oncol. 2025. PMID: 39755168 Free article.
1,043 results